EBIT at other companies
Other financials
Where this comes from
Calculated from Oruka Therapeutics, Inc.’s reported figures.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s EBIT?
- Oruka Therapeutics, Inc. (ORKA) reported EBIT of -$36.43M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s EBIT changed year-over-year?
- Oruka Therapeutics, Inc.'s EBIT decreased by 45.2% year-over-year, from -$25.09M to -$36.43M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Oruka Therapeutics, Inc.'s EBIT has grown at a 58.5% compound annual growth rate (CAGR), from -$19.34M to -$122.05M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.